KCNQ1/KCNE1 K+ channel and P2Y4 receptor are co-expressed from the time of birth in the apical membrane of rat strial marginal cells

Acta Otolaryngol Suppl. 2007 Oct:(558):30-5. doi: 10.1080/03655230701624830.

Abstract

Conclusion: KCNQ1/KCNE1 K(+) channels and P2Y(4) receptors are expressed in the apical membrane of rat strial marginal cells from postnatal day 1 (P1) and maintained throughout development.

Objectives: The purpose of the present study was to investigate the developmental expression of KCNQ1/KCNE1 K(+) channel and of P2Y(4), which is an important metabotropic regulator of KCNQ1/KCNE1 K(+) channel in strial marginal cells.

Materials and methods: Sprague-Dawley rats at different stages of development (P1, P3, P5, P7, P14, and P21) were studied. The spiral ligament with the stria vascularis was detached from the cartilaginous or bony cochlea and prepared for a voltage-sensitive vibrating probe and immunohistochemistry.

Results: Chromanol 293B, a blocker of KCNQ1/KCNE1 K(+) channel, inhibited short-circuit currents (I ( sc )) from P1 to P21. Similarly, I ( sc ) were found to be decreased by uridine 5'-triphosphate at all ages. The antagonist profiles indicated that the apical P2Y receptor is P2Y(4) subtype. KCNQ1, KCNE1, and P2Y(4) were immunolocalized in the apical region of stria vascularis at P1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Cell Membrane / metabolism*
  • Cells, Cultured
  • Chromans / pharmacology
  • Electrodes
  • Immunohistochemistry
  • KCNQ1 Potassium Channel / metabolism*
  • Potassium Channel Blockers / pharmacology
  • Potassium Channels, Voltage-Gated / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Purinergic P2 / metabolism*
  • Stria Vascularis / cytology*
  • Sulfonamides / pharmacology
  • Vibration

Substances

  • Chromans
  • KCNQ1 Potassium Channel
  • Kcne1 protein, mouse
  • Kcnq1 protein, mouse
  • Potassium Channel Blockers
  • Potassium Channels, Voltage-Gated
  • Receptors, Purinergic P2
  • Sulfonamides
  • purinoceptor P2Y4
  • 6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromane